1618
L. Vandromme et al.
LETTER
EtOAc) of the residue from the MeCN phase. See: Newman
W. P.; Synthesis; 1987, 665
(62.5 MHz, CDCl3): d = 168.4, 147.7, 135.3, 135.0, 132.4,
131.6, 130.8, 128.3, 127.0, 125.9, 125.7, 122.9, 84.8, 59.4,
42.8, 33.8, 27.6. IR (CHCl3): 1770 (C=O, Boc), 1694 (C=O,
amide) cm–1. [a]D20 +113.3 (c = 1, CHCl3).
Spectroscopic data : Compound 4a: 1H NMR (250 MHz,
CDCl3): d = 7.90 (1 H, dd, J = 7.8 Hz, J′ = 1.2 Hz), 7.20–7.56
(3 H, m), 6.11–6.14 (1 H, m), 5.64–5.68 (1 H, m), 5.35–5.39
(2 H, m), 5.05–5.11 (2 H, m), 4.75 (1 H, br s, NH), 3.58 (2
H, t, J = 6.0 Hz), 3.37 (2 H, d, J = 7.0 Hz). 13C NMR (62.5
MHz, CDCl3): d = 169.2, 147.5, 134.2, 132.8, 130.3, 128.9,
126.5, 124.7, 120.3, 118.0, 48.9, 39.2. IR (CHCl3): 1773
(C=O), 3368 (NH) cm–1. MS (CI, NH3): m/z = 298 [M +
Compound 17c: 1H NMR (200 MHz, CDCl3): d = 8.16 (1 H,
dd, J = 8.0 Hz, J¢ = 1.5 Hz), 7.64 (1 H, td, J = 15.0 Hz, J¢ =
1.5 Hz), 7.30–7.45 (7 H, m), 6.24–6.28 (1 H, m), 5.71–6.16
(2 H, m), 2.90–3.31 (2 H, m), 1.63 (9 H, s). 13C NMR (62.5
MHz, CDCl3): d = 167.9, 147.8, 140.3, 134.9, 132.5, 129.1,
128.1, 127.6, 126.2, 126.1, 125.9, 124.2, 119.9, 84.9, 62.2,
34.1, 27.8. IR (CHCl3): 1770.5 (C=O, Boc), 1699.3 (C=O,
lactam) cm–1.
+
NH4 ], 282 [MH+].
Compound 4b: 1H NMR (200 MHz, CDCl3): d = 6.86–7.90
(9 H, m), 5.90–6.10 (1 H, m), 5.54–5.71 (1 H, m), 5.21–5.33
(2 H, m), 4.92–5.01 (2 H, m), 4.79 (1 H, d, J = 7.3 Hz, NH),
3.95–4.10 (1 H, m), 3.33 (2 H, d, J = 7.2 Hz), 2.80 (2 H, d,
J = 6.8 Hz). 13C NMR (62.5 MHz, CDCl3): d = 168.7, 147.3,
136.7, 136.1, 133.8, 129.9, 129.5, 129.4, 128.6, 128.5,
126.9, 126.1, 124.5, 119.9, 116.4, 57.4, 42.0, 39.0.
(18) Experimental Procedure: To a solution of 18 (40 mg, 0.116
mmol) in THF (2 mL) was added LiAlH4 (4 mg, 0.116
mmol, 1 equiv) at r.t. The reaction was stirred for 3 h and
quenched with a solution of 0.1 M HCl. The aqueous layer
was extracted with CH2Cl2 (3 × 10 mL). The combined
organic phases were dried with MgSO4 and concentrated in
vacuo. The resulting oil was then chromatographed on silica
gel column (EtOAc–heptane, 20:80) to give the alcohol 20.
Yield: 74% (30 mg, 0.086 mmol).
Compound 4c: 1H NMR (250 MHz, CDCl3): d = 6.90–7.80
(9 H, m), 5.76–6.11 (2 H, m), 5.00–5.30 (4 H, m), ca. 5.2
(1 H, NH) 4.80–4.95 (1 H, t, J = 15 Hz), 3.35 (2 H, d, J = 6.9
Hz). 13C NMR (62.5 MHz, CDCl3): d = 168.7, 147.3, 138.9,
136.7, 133.9, 132.4, 130.0, 129.8, 128.7, 127.9, 127.1,
126.1, 124.3, 120.3, 117.1, 60.2, 39.3. IR (liquid film):
1772.2 (C=O), 3294.2 (NH) cm–1. MS (CI, NH3): m/z = 375
Compound 20: 1H NMR (300 MHz, CDCl3): d = 8.71 (1 H,
s), 6.96–7.56 (m, 9 H), 5.31–5.42 (2 H, m), 4.91–4.94 (1 H,
br d, NH), 4.23–4.32 (1 H, m), 3.45 (2 H, t, J = 6.4 Hz), 2.91
(1 H, dd, J = 13.5 Hz, J¢ = 6.0 Hz), 2.78 (1 H, dd, J = 13.5
[M + NH4 ], 358 [MH+].
Hz, J¢ = 7.9 Hz), 1.91–2.11 (2 H, 2 × symmetrical m). 13
NMR (75 MHz, CDCl3): d = 155.2, 136.2, 135.3, 130.9,
C
+
(14) Greene, T. W.; Wuts, P. G. M. Protective Group in Organic
Synthesis, 3rd ed.; Wiley: New York, 1999.
(15) The absence of ester IR carbonyl absorption in the range
1750–1700 cm–1 is coherent with the O-silylated N-acylated
structure as represented in 15; the alternative N-silylated O-
acylated may be confidently dismissed.
(16) Typical Experimental Procedure: To a solution of
N-1-benzylallyl-o-(but-3-enoyloxy)benzene-sulfonamide
(4b; 1.7 mmol) in anhyd CH2Cl2 (12 mL) were added
successively Boc2O (1.72 mmol) and DMAP (0.08 mmol, ca
0.05 equiv). The reaction mixture was then stirred at r.t. with
TLC monitoring. After completion, the reaction mixture was
diluted with EtOAc and washed successively with aq 1 M
HCl and aq NaHCO3. The organic phase was dried,
concentrated and the residue was purified by column
chromatography (silica gel, cyclohexane–EtOAc, 9:1) to
give N-1-benzylallyl-N-but-3-enoyl-(o-tert-butoxycarbonyl-
oxy)benzenesulfonamide (16b) as a colorless oil (yield:
79%).
129.7, 129.6, 128.7, 128.6, 127.1, 123.2, 120.5, 118.8, 61.6,
52.5, 42.2, 30.8. HRMS (ESI): m/z [M + Na+] calcd for
C18H21O4NNaS: 370.1068; found: 370.10787.
(19) Experimental Procedure: To a stirred solution of 18 (50
mg, 0.146 mmol) in THF (2 mL) at –78 °C was added slowly
a 1.1 M solution of diisobutylaluminum hydride in cyclo-
hexane (0.4 mL, 0.44 mmol, 3 equiv). The solution was
warmed to 0 °C and quenched with a solution of 0.1 M HCl.
The layers were separated and the aqueous phase was
extracted with CH2Cl2 (3 × 5 mL). The combined organic
phases were dried with MgSO4 and concentrated in vacuo.
The resulting oil was then chromatographed on silica gel
column (EtOAc–heptane, 30:70). Compound 21 was
obtained as a 85:15 mixture of the two possible diastereo-
isomers. Yield: 60% (32 mg, 0.088 mmol).
Spectroscopic data: Compound 21 (major diastereoisomer):
1H NMR (360 MHz, CDCl3): d = 7.80 (1 H, dd, J = 8.1 Hz,
J¢ = 1.5 Hz), 7.44–7.47 (1 H, m), 7.19–7.35 (5 H, m), 6.92 (1
H, d, J = 8.6 Hz), 6.17–6.19 (1 H, m), 5.76–5.82 (2 H, m),
4.20–4.22 (1 H, m), 3.41 (1 H, dd, J = 13.1 Hz, J¢ = 2.8 Hz),
3.11 (1 H, dd, J = 13.2 Hz, J¢ = 8.3 Hz), 2.41–2.57 (1 H, m),
2.18–2.24 (1 H, m). 13C NMR (75 MHz, CDCl3): d = 134.2,
134.1, 130.4, 129.4, 128.5, 128.0, 127.3, 126.5, 125.2,
124.7, 122.3, 121.7, 119.7, 119.5, 118.2, 83.9, 54.9, 42.9,
24.6. HRMS (ESI): m/z [MH+ – H2O] calcd for C18H18O3NS:
328.1002; found: 328.10030.
Spectroscopic data: Compound 16b: 1H NMR (200 MHz,
CDCl3): d = 7.30–8.03 (9 H, m), 5.91–6.23 (2 H, m), 5.10–
5.23 (2 H, m), 4.58–4.90 (2 H, m), 4.50–4.58 (1 H, m), 3.71
(2 H, d, J = 6.8 Hz), 3.31–3.42 (1 H, dd, J = 13.2 Hz, J¢ = 9.3
Hz), 3.00–3.09 (1 H, dd, J = 13.2 Hz, J¢ = 5.0 Hz), 1.58
(s, 9 H). IR (CHCl3): 1769 (C=O, Boc), 1702.1 (C=O,
amide) cm–1.
Compound 16c (yield: 93%): 1H NMR (200 MHz, CDCl3):
d = 7.30–8.20 (9 H, m), 6.35–6.55 (1 H, m), 5.80–6.00 (1 H,
m), 5.76 (1 H, d, J = 6.4 Hz), 5.10–5.20 (2 H, m), 5.00–5.48
(2 H, m), 3.50–3.80 (m, 2 H), 1.58 (s, 9 H). IR (CHCl3): 1769
(C=O, Boc), 1702.1 (C=O, amide) cm–1.
(20) In particular, several alkene pseudodipeptidic entities have
been obtained by oxidation of alcohols precursors: (a) cis-
Proline mimics: ref. 1b, 1d. (b) E-Alkene analogues: Bol,
K. M.; Liskamp, R. M. J. Tetrahedron 1992, 48, 6425.
(c) Bohnsted, A.; Prasad, V.; Rich, D. H. Tetrahedron Lett.
1993, 34, 5217. (d) Yong, Y. F.; Lipton, M. A. Bioorg. Med.
Chem. Lett. 1993, 3, 2879. (e) Xiao, J.; Weisblum, B.; Wipf,
P. Org. Lett. 2006, 8, 4731.
(17) Spectroscopic data: Compound 17b: 1H NMR (200 MHz,
CDCl3): d = 7.27–8.25 (9 H, Ar, m), 5.84–5.93 (1 H, m),
5.64–5.72 (1 H, m), 5.40–5.53 (1 H, m), 3.10–3.31 (2 H, m),
2.46–2.59 (1 H, dd, J = 21.5 Hz, J¢ = 5.1 Hz), 1.90–2.02
(1 H, dd, J = 21.5 Hz, J¢ = 2.9 Hz), 1.58 (s. 9H). 13C NMR
Synlett 2009, No. 10, 1614–1618 © Thieme Stuttgart · New York